Mon, Sep 15, 2014, 12:31 AM EDT - U.S. Markets open in 8 hrs 59 mins

Recent

% | $
Quotes you view appear here for quick access.

EntreMed, Inc. Message Board

  • tborges732 tborges732 Aug 31, 2005 2:05 PM Flag

    P1b trial to finish in September...

    Burn's August letter to investors states... "The Phase 1b trials remain on track and we anticipate completing our study objectives this quarter and presenting the results at a scientific meeting this fall."

    http://www.entremed.com/

    We begin countdown as we enter September, the last month of the quarter... I would guess that the Multiple Myeloma P2 trials currently underway will be a major focus...

    The scientific meeting has not yet been announced... there are many... September through NOvember.

    In the absence of any bad news (all news has been positive... from pre-clinical trials to new indications <RA>)... there is, in my opinion, many good reasons to be very optimistic...

    The most compelling reason is the design of the Phase 2 trials to begin "in 2005," in the next four months, will be multi-level... targeting different disease based upon indications from the P1b trial, previousl P1-P2 trials with Panzem capsules and pre-clinical observations...

    The remaining days of 2005 will be very interesting...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ENMD
1.740.00(0.00%)Jun 13 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
21Vianet Group, Inc.
NasdaqGSFri, Sep 12, 2014 4:00 PM EDT
Darden Restaurants, Inc.
NYSEFri, Sep 12, 2014 4:03 PM EDT